Viewing Study NCT00082966


Ignite Creation Date: 2025-12-24 @ 4:22 PM
Ignite Modification Date: 2026-06-15 @ 5:56 PM
Study NCT ID: NCT00082966
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2004-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Lymphocyte Depletion Hodgkin Lymphoma View
None Adult Mixed Cellularity Hodgkin Lymphoma View
None Adult Nodular Sclerosis Hodgkin Lymphoma View
None Recurrent Adult Hodgkin Lymphoma View
Keywords: